Search for: "FTC"
Results 641 - 660
of 20,444
Sort by Relevance
|
Sort by Date
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 9:00 pm
Their relationships on the state level may also open up new channels for FTC partnership with state attorneys general. [read post]
7 Mar 2024, 2:08 pm
Attorney advertising Photo by rupixen on Unsplash Similar Blog Posts: FTC Guidelines on Negative Option Marketing Released Social Media Influencers and FTC Lawsuits LendEDU to Settle Alleged FTC Marketing Law Violations The post CFPB Releases Comparison Shopping Warning appeared first on Klein Moynihan Turco. [read post]
7 Mar 2024, 7:54 am
On January 25, 2024, the Federal Trade Commission (FTC) hosted a summit focused on the impact of artificial intelligence (AI) on consumers and competition in the technology sector. [read post]
7 Mar 2024, 6:59 am
Regulatory and Administrative Initiatives (1 matter) FTC FOCUSES ON INDEPENDENT CONTRACTOR MISCLASSIFICATION AS FORM OF UNFAIR COMPETITION. [read post]
6 Mar 2024, 12:40 pm
Featuring speakers from the USPTO, FTC, FDA, distinguished members of the Judiciary, and in-house and outside counsel, HP&M Director Kurt Karst will be a presenter at the 20th Annual Paragraph IV Disputes Conference, April 25 – 26 in New York, NY. [read post]
6 Mar 2024, 12:34 pm
FTC Chair Lina Khan stated, “When private equity firms buy out healthcare facilities only to slash staffing and cut quality, patients lose out. [read post]
6 Mar 2024, 11:52 am
On March 5, 2024, the Federal Trade Commission (“the FTC”) hosted a public workshop titled “Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care”, which covered the impact of private equity investment on the health care system. [read post]
6 Mar 2024, 11:45 am
SEC Chair Gensler, a most activist sort of regulator, has pushed through very many programs favored by the Left; same can be said for other agencies, particularly the FTC and DOJ in antitrust regulation (for which see several prior posts to this site). [read post]
6 Mar 2024, 10:09 am
That’s why EFF has urged the FTC and DOJ to consider privacy impacts when scrutinizing proposed mergers: not just to protect internet users from the harms of surveillance business models, but to protect democracy from the corrupting influence of surveillance cartels. [read post]
6 Mar 2024, 5:56 am
[Slate] * Biden launches bid to crack down on profiteering by setting up a brand new strike force that sounds... exactly like the FTC. [read post]
5 Mar 2024, 7:24 pm
“Three recent FTC enforcement actions reflect a heightened focus on pervasive extraction and mishandling of consumers’ sensitive personal data. [read post]
5 Mar 2024, 5:00 am
Both the CFPB and the FTC have reporting obligations. [read post]
4 Mar 2024, 7:39 pm
As The Markup notes, the FTC agreed, and an order this week blocked the sale or transfer of a huge trove of user data…” [read post]
4 Mar 2024, 4:31 am
Maureen Ohlhausen, his immediate predecessor and another FTC veteran, also appointed someone who knew the agency well and who’d worked in both of the FTC’s enforcement bureaus. [read post]
